MAPT and Alzheimer disease: Then, we monitored the expression of untagged tau over time using western blot analysis and assessed whether tau phosphorylation occurred at Ser199/202, which are key residues implicated in tau aggregation in Alzheimer’s disease in all six isoforms [20, 21].